Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?

Alana T. Brennan, Mary Ann Davies, Jacob Bor, Gilles Wandeler, Kathryn Stinson, Robin Wood, Hans Prozesky, Frank Tanser, Geoffrey Fatti, Andrew Boulle, Izukanji Sikazwe, Kara Wool-Kaloustian, Constantin Yuannoutsos, Valeriane Leroy, Nathalie De Rekeneire, Matthew P. Fox

Research output: Contribution to journalArticle

5 Scopus citations

Fingerprint Dive into the research topics of 'Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?'. Together they form a unique fingerprint.

Medicine & Life Sciences